Filtered By:
Specialty: Cancer & Oncology
Procedure: Radiography
This page shows you your search results in order of date.
Order by Relevance | Date
Total 631 results found since Jan 2013.
Left epigastric isolated tumor fed by the inferior phrenic artery diagnosed as ectopic hepatocellular carcinoma: A case report
CONCLUSION: This asymptomatic ectopic HCC case described achieved an excellent result due to early detection, radical resection, and systematic surveillance.PMID:37731571 | PMC:PMC10507550 | DOI:10.12998/wjcc.v11.i26.6231
Source: Clinical Lung Cancer - September 21, 2023 Category: Cancer & Oncology Authors: Hong-Bo Liu Li-Hua Zhao Yong-Jian Zhang Zhi-Feng Li Lei Li Qian-Peng Huang Source Type: research
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial
This study is registered with ClinicalTrials.gov, NCT03732820, and is completed and no longer recruiting.FINDINGS: Between Oct 31, 2018 and March 11, 2020, 1103 patients were screened, of whom 399 were randomly assigned to olaparib plus abiraterone and 397 to placebo plus abiraterone. Median follow-up for overall survival in patients with censored data was 36·6 months (IQR 34·1-40·3) for olaparib plus abiraterone and 36·5 months (33·8-40·3) for placebo plus abiraterone. Median overall survival was 42·1 months (95% CI 38·4-not reached) with olaparib plus abiraterone and 34·7 months (31·0-39·3) with placebo plus a...
Source: Cancer Control - September 15, 2023 Category: Cancer & Oncology Authors: Fred Saad Noel W Clarke Mototsugu Oya Neal Shore Giuseppe Procopio Jo ão Daniel Guedes Cagatay Arslan Niven Mehra Francis Parnis Emma Brown Friederike Schl ürmann Jae Young Joung Mikio Sugimoto Oliver Sartor Yu-Zhen Liu Christian Poehlein Laura Barker P Source Type: research
Treatment Variation and Long-Term Outcomes of Low-Grade Appendiceal Neoplasms
CONCLUSIONS: Significant variation exists in treatment patterns for LAMNs, particularly prior to referral to a high-volume center. Patients frequently underwent colectomy without apparent oncologic benefit. In the current era of high-quality cross sectional imaging, routine use of DL has low yield and is not recommended. Recurrence in this population is rare, and low-intensity surveillance can be offered. Overall prognosis is excellent, even with peritoneal disease.PMID:37702905 | DOI:10.1245/s10434-023-13501-8
Source: Ann Oncol - September 13, 2023 Category: Cancer & Oncology Authors: Michael G White Neal Bhutiani Beth A Helmink Melissa Taggart Wai Chin Foo Paul F Mansfield Keith F Fournier Christopher P Scally Source Type: research
Predicting successful clinical candidates for fiducial-free lung tumor tracking with a deep learning binary classification model
CONCLUSIONS: A deep learning model can distinguish features of trackable and untrackable lesions in DRR images, and can predict successful candidates for fiducial-free lung tumor tracking.PMID:37696265 | DOI:10.1002/acm2.14146
Source: Clinical Lung Cancer - September 11, 2023 Category: Cancer & Oncology Authors: Matthieu Lafreni ère Gilmer Valdes Martina Descovich Source Type: research
A retrospective study of sinonasal tumors in 182 dogs treated with stereotactic radiotherapy (3 × 10 Gy) (2010-2015)
CONCLUSIONS AND CLINICAL IMPORTANCE: Results are comparable to other reports of treatment of SRT. Acute morbidities were minimal. Modified Adams stage scheme appeared to be inappropriate for prognostication for dogs with sinonasal tumors treated with SRT.PMID:37688322 | DOI:10.1111/jvim.16838
Source: Cancer Control - September 9, 2023 Category: Cancer & Oncology Authors: Hiroto Yoshikawa Mary H Lafferty Lynn R Griffin Susan M LaRue Source Type: research
Fracture healing in a polytrauma rat model is influenced by mtDNA:cGAS complex mediated pro-inflammation
CONCLUSIONS: These data reveal that the cGAS-STING signaling pathway influences trauma-induced delayed bone healing. However, further evaluation of this pathway at the cellular and molecular levels to augment PT associated detrimental effects is needed.PMID:37656236 | DOI:10.1186/s40634-023-00637-5
Source: Cancer Control - September 1, 2023 Category: Cancer & Oncology Authors: Preeti J Muire Alicia L Lofgren Stefanie M Shiels Joseph C Wenke Source Type: research
Nodular Pulmonary Amyloidosis Preceding Gastric Mucosa-associated Lymphoid Tissue Lymphoma, Initially Suspected to Be Lung Cancer
In this report, we describe a case of a 76-year-old male who presented with a solitary nodule in his left lower lung lobe on computed tomography that increased from 6 mm to 13 mm in diameter over 40 months. Lung cancer was suspected; however, transbronchial lung biopsy revealed deposition of an eosinophilic and homogeneous amorphous substance, which showed apple-green birefringence under polarized light after Congo red staining, and immunohistochemistry analysis returned positive results for immunoglobulin lambda light-chain. Upper gastrointestinal endoscopy revealed a gastric mucosa-associated lymphoid tissue (MALT) lymph...
Source: Clinical Lung Cancer - August 27, 2023 Category: Cancer & Oncology Authors: Naokata Kutsuzawa Hiroto Takiguchi Haruka Ikoma Nobue Kumaki Tomoo Nagai Mitsuharu Ueda Yoshitaka Ono Yukihiro Horio Kyoko Niimi Naoki Hayama Yoko Ito Tsuyoshi Oguma Koichiro Asano Source Type: research
Combined RAF and MEK Inhibition to Treat Activated Non-V600 BRAF-Altered Advanced Cancers
CONCLUSION: Combined RAF and MEK inhibition does not sufficiently inhibit activated non-V600 BRAF-mutant tumors in patients.PMID:37616543 | DOI:10.1093/oncolo/oyad247
Source: The Oncologist - August 24, 2023 Category: Cancer & Oncology Authors: Naryan Rustgi Ann Maria Nicolas Toumbacaris HuiYong Zhao Katherine Kargus Morgan Bryant Alexandra Waksmundzki Ilinca Aricescu Robert A Lefkowitz Bob T Li Joanne Chou Marinela Capanu Elisa de Stanchina Sandra Misale Jinru Shia Rona Yaeger Source Type: research
Interstitial lung abnormalities after hospitalization for COVID-19 in patients with cancer: A prospective cohort study
CONCLUSIONS: Post-COVID-19 ILAs are common in cancer patients 3 months after hospital discharge, and peak RSI and older age are strong predictors of persistent ILAs.PMID:37592894 | DOI:10.1002/cam4.6396
Source: Cancer Control - August 18, 2023 Category: Cancer & Oncology Authors: Sungryong Noh Christopher Bertini Isabel Mira-Avendano Maryam Kaous Bela Patel Saadia A Faiz Vickie R Shannon Diwakar D Balachandran Lara Bashoura Roberto Adachi Scott E Evans Burton Dickey Carol Wu Girish S Shroff Joanna-Grace Manzano Bruno Granwehr Shan Source Type: research
Randomized Phase II Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer
CONCLUSION: AAP + C was safe with improved rPFS, OS duration, and a higher proportion of PSA declines. This suggests that AAP + C given earlier rather than sequentially may benefit some men. Further work is needed to identify this population.PMID:37582240 | DOI:10.1200/JCO.22.02639
Source: Clinical Prostate Cancer - August 15, 2023 Category: Cancer & Oncology Authors: Susan F Slovin Karen Knudsen Susan Halabi Renee de Leeuw Ayesha Shafi Praneet Kang Steven Wolf Bin Luo Anuradha Gopalan Tracy Curley Mark Fleming Ana Molina Celina Fernandez Kevin Kelly Source Type: research
Surgeon and Radiologist Evaluation of Electromagnetic Chip Localization for Benign and Malignant Breast Lesions
CONCLUSION: There was successful EMC deployment by radiologists with accurate visualization and successful surgical excision in most cases. The EnVisioTM SmartClipTM system is a reproducible and accurate localization method for benign and malignant breast lesions.PMID:37552349 | DOI:10.1245/s10434-023-13976-5
Source: Ann Oncol - August 8, 2023 Category: Cancer & Oncology Authors: Nicholas T Champion Blaise Mooney Youngchul Kim Junmin Whiting Weihong Sun John Kiluk Brian Czerniecki Susan Hoover Marie Catherine Lee Source Type: research
Depth of radiographic response (DpR) and time to tumor regrowth (TTG) predicts overall survival following anti-VEGF therapy in recurrent glioblastoma
CONCLUSIONS: Recurrent glioblastoma patients with a large, durable radiographic response to anti-angiogenic agents have significantly longer survival. This information is useful for interpreting activity of anti-angiogenic agents in recurrent glioblastoma.PMID:37540556 | DOI:10.1158/1078-0432.CCR-23-1235
Source: Clinical Cancer Research - August 4, 2023 Category: Cancer & Oncology Authors: Benjamin M Ellingson Akifumi Hagiwara Connor J Morris Nicholas S Cho Sonoko Oshima Francesco Sanvito Talia C Oughourlian Donatello Telesca Catalina Raymond Lauren E Abrey Josep Garcia Dana T Aftab Colin Hessel Tamar Rachmilewitz Minei Dror Harats David A Source Type: research
